rs121965087

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PS3PM2PP5_Moderate

The NM_000235.4(LIPA):​c.129C>G​(p.Tyr43*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000141 in 1,418,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). ClinVar reports functional evidence for this variant: "SCV001406566: This variant has been reported to affect LIPA protein function (PMID:29196158).". Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

LIPA
NM_000235.4 stop_gained

Scores

5
2

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 2.30

Publications

1 publications found
Variant links:
Genes affected
LIPA (HGNC:6617): (lipase A, lysosomal acid type) This gene encodes lipase A, the lysosomal acid lipase (also known as cholesterol ester hydrolase). This enzyme functions in the lysosome to catalyze the hydrolysis of cholesteryl esters and triglycerides. Mutations in this gene can result in Wolman disease and cholesteryl ester storage disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]
LIPA Gene-Disease associations (from GenCC):
  • lysosomal acid lipase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • lysosomal acid lipase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women's Health, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • cholesteryl ester storage disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Wolman disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000235.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PS3
PS3 evidence extracted from ClinVar submissions: SCV001406566: This variant has been reported to affect LIPA protein function (PMID: 29196158).
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-89245776-G-C is Pathogenic according to our data. Variant chr10-89245776-G-C is described in ClinVar as Pathogenic. ClinVar VariationId is 82.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000235.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIPA
NM_000235.4
MANE Select
c.129C>Gp.Tyr43*
stop_gained
Exon 3 of 10NP_000226.2P38571-1
LIPA
NM_001440836.1
c.261C>Gp.Tyr87*
stop_gained
Exon 4 of 11NP_001427765.1
LIPA
NM_001440837.1
c.129C>Gp.Tyr43*
stop_gained
Exon 3 of 10NP_001427766.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIPA
ENST00000336233.10
TSL:1 MANE Select
c.129C>Gp.Tyr43*
stop_gained
Exon 3 of 10ENSP00000337354.5P38571-1
LIPA
ENST00000428800.5
TSL:1
c.129C>Gp.Tyr43*
stop_gained
Exon 2 of 7ENSP00000388415.1Q5T073
LIPA
ENST00000868683.1
c.129C>Gp.Tyr43*
stop_gained
Exon 3 of 10ENSP00000538742.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000141
AC:
2
AN:
1418858
Hom.:
0
Cov.:
25
AF XY:
0.00000141
AC XY:
1
AN XY:
708602
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32672
American (AMR)
AF:
0.00
AC:
0
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25854
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39476
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85352
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53348
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5714
European-Non Finnish (NFE)
AF:
0.00000186
AC:
2
AN:
1072836
Other (OTH)
AF:
0.00
AC:
0
AN:
58938
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Wolman disease (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.62
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
37
DANN
Uncertain
1.0
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.78
D
PhyloP100
2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs121965087;
hg19: chr10-91005533;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.